Press Releases

Press Releases

Espero Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the appointment of industry veteran Wayne Yetter as a member of the board of directors. Mr. Yetter has more than 30 years of industry experience, with leadership positions at global pharmaceutical companies including President and CEO of Novartis Pharmaceutical…

Press Releases

TissueGene, Inc. (TGI), a regenerative medicine company using cell and gene therapy to develop novel regenerative drugs, is pleased to announce the appointment of Gurdyal Kalsi, M.D., to the role of Chief Medical Officer, SVP Clinical Development & Medical Affairs. Dr. Kalsi will oversee and direct the clinical development of…

Press Releases

Diplomat Pharmacy, Inc., the nation's largest independent specialty pharmacy, will release its fourth quarter and year end 2015 operating results on Monday, February 29, 2016 after market close, with a conference call to follow at 5:00p.m. Eastern Time. Shareholders and interested participants may listen to a live broadcast of the…

Press Releases

Governor Andrew M. Cuomo today announced a major expansion of Athenex that will create 1,400 jobs throughout Western New York. This announcement, made possible by a partnership with the SUNY Polytechnic Institute, includes a major expansion of Athenex's North American headquarters at the Conventus Building in Buffalo, as well as…

Press Releases

Perrigo Company plc today announced that it will announce financial results for its calendar year and fourth quarter 2015 on Thursday, February 18, 2016 at approximately 6:00 a.m. (ET). The Company will conduct a conference call at 8:00 a.m. (ET) hosted by Joseph C. Papa, Perrigo's Chairman and Chief Executive…

Press Releases

Navidea Biopharmaceuticals, Inc., today announced that the first patient has been enrolled in a clinical study evaluating Lymphoseek® (technetium Tc 99m tilmanocept) injection in women with known cervical cancer. The study, funded by a Fast-track grant from the National Institutes of Health (NIH), National Cancer Institute (NCI; 1R44CA180390-01) will assess…

Press Releases

Resolve Therapeutics, LLC, a clinical stage biopharmaceutical company developing potentially transformative new approaches to the treatment of lupus and Sjogrens syndrome, today announced the successful completion of a multiple ascending dose study in patients with systemic lupus erythematosus (SLE) with its lead compound RSLV-132. Data from a multicenter phase double-blind,…

Press Releases

Lonza Houston, Inc., a global leader in viral gene therapy manufacturing, and Renova™ Therapeutics, a biopharmaceutical company developing gene therapy treatments for congestive heart failure and other chronic diseases, have entered into a Manufacturing Services Agreement to develop a scalable manufacturing process and produce cGMP-grade RT-100 (Ad5.hAC6) Drug Product for…

Press Releases

Shire plc and Shionogi & Co., Ltd. recently announced that Shionogi submitted a New Drug Application (NDA) for the manufacturing and marketing in Japan of S-877503 (guanfacine hydrochloride prolonged release tablets),* for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children. The Japanese clinical studies were conducted in children 6 to…

Press Releases

Jazz Pharmaceuticals plc announced that it will report its 2015 fourth quarter and full year financial results on Tuesday, February 23, 2016, after the close of the financial markets.  Company management will host a live audio webcast immediately following the announcement at 4:30 p.m. EST/9:30 p.m. GMT to discuss fourth…